IBA’s RADIOMED ANNOUNCES SHONIN APPROVAL FOR VISICOIL MARKERSBartlett, TN., July 29, 2011
WILEX and IBA report on the Pre-BLA Meeting with the FDA and the next steps in the REDECTANE® approval processMunich, Germany, and Louvain-la-Neuve, Belgium, June 17, 2011
The IBA IntegraLab® team supports PET centers to be compliant with the new FDA regulationsLouvain-la-Neuve, Belgium, May 26, 2011
IBA patented its dual proton source for PET Cyclotrons Louvain-la-Neuve, Belgium, May 20, 2011
TRADING UPDATE- FIRST QUARTER 2011Louvain-la-Neuve, Belgium, May 11, 2011
IBA cooperates with Philips to create patient-centric proton therapy centersLondon, UK and Philadelphia, USA , May 9, 2011
IBA TAKES A 25 % STAKE IN PET NET GERMANY AND REINFORCES GLOBAL PET RADIOPHARMACEUTICALS NETWORKLouvain-la-Neuve, Belgium, April 18, 2011
IBA signs a contract with Skandionkliniken for the installation of Scandinavia first dedicated proton therapy centerStockholm, Sweden, March 17, 2011
IBA continues to reinforce its leadership in Proton TherapyLouvain-la-Neuve, Belgium, January 19, 2011
IBA selected for a new Proton Therapy Center in Dresden, GermanyLouvain-la-Neuve, Belgium, January 17, 2011
IBA SELECTED TO INSTALL A PROTON THERAPY CENTER IN KNOXVILLE, TENNESSEE, USALouvain-la-Neuve, Belgium, November 2, 2010
IBA Introduces Proteus ONE*, a Smaller, More Cost-Effective Proton Therapy SystemSan Diego, October 31, 2010
IBA Introduces Proteus ONE*, a Smaller, More Cost-Effective Proton Therapy SystemSan Diego, U.S.A, October 31, 2010
New Industry Partnership will Secure Manufacturing of Radioisotopes for Medical Use in EuropeGif-sur-Yvette, France, September 2, 2010
IBA and Bayer Schering Pharma Sign Clinical Trial Supply Agreement for Alzheimer’s Disease TracerLouvain-la-Neuve, Belgium, August 27, 2010
IBA Signs a Contract for the New Proton Therapy Center of Cracow, PolandLouvain-la-Neuve, Belgium, August 2, 2010
PROCURE SELECTS IBA ONE MORE TIME AS SUPPLIER FOR A PROTON THERAPY SYSTEMLouvain-la-Neuve, Belgium, July 5, 2010
IBA Molecular presents an all-new version of its Synthera® at SNM’10Louvain-la-Neuve, Belgium, June 4, 2010
REDECTANE® meets both endpoints specificity and sensitivity withMunich, Germany, and Louvain-la-Neuve, Belgium,, May 18, 2010
Frost & Sullivan lauds IBA for its Technology Dominance in the European Radiopharmaceuticals MarketSaclay, France, April 23, 2010
CE Certification Granted for IBA’s 2nd Generation Pencil Beam Scanning Proton Treatment SystemBelgium, Lovain-la-Neuve, April 15, 2010
DASHENG AND IBA HAVE ENTERED AN EXCLUSIVE AGREEMENT China, April 1, 2010
IBA 2009 full year resultsLouvain-la-Neuve, Belgium, March 15, 2010
New Proton Therapy OrderLouvain-la-Neuve, Belgium, February 23, 2010
IBA ANNOUNCES ONE-TIME CHARGES FOR 2009 ARISINGLouvain-la-Neuve, Belgium, February 19, 2010
IBA shares buybackLouvain-la-Neuve, Belgium, December 22, 2009
The EIB provides IBA with EUR 50 million for R&D projects in the fields of cancer diagnosis and therapyLouvain-la-Neuve, Belgium, December 17, 2009
IBA shares buybackLouvain-la-Neuve, Belgium, December 4, 2009
IBA prevails in first instance in its cancellation claim of the Protontherapy contract of Skandion in Sweden.Louvain-la-Neuve, Belgium, December 4, 2009
IBA and AtreP sign a contract to open the 1st Gantry Equipped proton therapy center in Trento (Italy)Louvain-la-Neuve, Belgium, December 3, 2009
Third Quarter 2009 Interim StatementLouvain-la-Neuve, Belgium, November 18, 2009
PROTEUS NANO, THE NEW TOW-ROOM SOLUTION FROM IBALouvain-la-Neuve, Belgium, November 2, 2009
IBA launches MaxiPRO, an innovative rental solutionLouvain-la-Neuve, Belgium, October 29, 2009
IBA RECEIVES POSITIVE OPINION FOR SCINTIMUN® Louvain-la-Neuve, Belgium, October 29, 2009
Shares BuybackLouvain-la-Neuve, Belgium, October 27, 2009
Shares BuybackLouvain-la-Neuve, Belgium, October 13, 2009
Last patient treated in the REDECTANE® phase III registration trialLouvain-la-Neuve, Belgium, October 6, 2009
IBA and AposenseLouvain-la-Neuve, Belgium and Petach-Tikva, Israel, September 21, 2009
New scientific publications about COMPASS available for download!University Medical Center in Groningen, The Netherlands, September 11, 2009
Financial Results at June 30, 2009Louvain-la-Neuve, Belgium, August 31, 2009
IBA and Eczacıbaşı-Monrol realized the first major step of the MOU signed in February.Louvain-la-Neuve, Belgium, August 28, 2009
IBA and ProCure set new world record in Proton Therapy, opening the Oklahoma Center nine months ahead of standard schedule.Louvain-la-Neuve, Belgium, August 27, 2009
IBA Dosimetry launched new 3D water phantom at AAPMAnnual Meeting in Anaheim , California, July 26, 2009
Data concerning transparency - Capital increaseLouvain-la-Neuve, Belgium, July 20, 2009
IBA SELECTED TO INSTALL THE FIRST GANTRY-EQUIPPED PROTON THERAPY SYSTEM OF ITALY, IN TRENTOLouvain-la-Neuve, Belgium, July 17, 2009
New COMPASS abstract available for download!Belguim, July 10, 2009
COMPASS software version 2.0 released now!Belguim, June 24, 2009
Data concerning transparency - Capital increaseLouvain-la-Neuve, Belgium, June 12, 2009
The Cyclone 11 at SNM'09Louvain-la-Neuve, Belgium, June 8, 2009
IBA Molecular presents the Cyclone® 11 at SNM’09Louvain-la-Neuve, Belgium, June 8, 2009
IBA and BV Cyclotron VU extend partnership in PET tracers supplyLouvain-la-Neuve, Belgium and Amsterdam, The Netherlands, May 29, 2009
First Quarter 2009 Interim Statement Louvain-la-Neuve, Belgium, May 8, 2009
IBA SELLS A PROTON THERAPY SYSTEM IN PRAGUELouvain-la-Neuve, Belgium, May 8, 2009
ProCure and IBA Announce FDA Clearance of a New Generation Patient Positioning System Device Developed to Improve Proton TherapyBloomington, Ind., USA and Louvain-la-Neuve, Belgium, April 29, 2009
Data concerning transparency - Capital increaseLouvain-la-Neuve, Belgium, April 21, 2009
IBA SELL A NEW VERSION OF ITS FAMOUS CYCLONE 30® IN GERMANYLouvain-la-Neuve, Belgium, March 24, 2009
IBA Year-End Results for 2008Louvain-la-Neuve, Belgium, March 5, 2009
Revolutionary proton therapy cures boy, 5,of brain tumourBelguim, February 25, 2009
IBA AND ECZACIBASI-MONROL JOIN FORCES TO GROW MARKET FORRADIOPHARMACEUTICALS IN SEVERAL REGIONSLouvain-la-Neuve, Belgium and Gebze, Turkey, February 2, 2009
Mass. General Cancer Center Now Offers Pencil-Beam Proton Therapy TreatmentBoston, MA, January 29, 2009
IBA – Data concerning transparency - Capital increaseLouvain-la-Neuve, Belgium, January 28, 2009
